|
| Biotinylated Human TGFBR1 Protein (LTP10141) |
|
| LTP10141 |
|
| 100ug |
|
|
$789 In stock |
| transforming growth factor beta receptor 1 (TGFBR1), a key stimulator of tumor proliferation and metastasis, was a direct target of miR?98?5p. miR?98?5p overexpression resulted in the downregulation of TGFBR1 and the suppression of the viability, proliferation, migration and invasion of A549 and H1299 cells. |
| Recombinant Biotinylated Human TGFBR1 Protein is expressed from Expi293 with mFc (IgG1) tag and Avi tag at the C-terminal. It contains Leu34-Glu125. |
|
| TGFBR1 |
|
| Human |
|
| P36897-1 |
|
| Leu34-Glu125 |
|
| The protein has a predicted MW of 38.2 kDa. Due to glycosylation, the protein migrates to 50-55 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-mFc-Avi |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
